Alcohol consumption and survival of colorectal cancer patients: A population-based study from Germany

American Journal of Clinical Nutrition

Volumn 103, Issue 6, 2016, Pages 1497-1506

  Walter, Viola ^a   Jansen, Lina ^a   Ulrich, Alexis ^b   Roth, Wilfried ^a,b   Bläker, Hendrik ^c   Chang Claude, Jenny ^a   Hoffmeister, Michael ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alcohol consumption; Colorectal neoplasms; Prognosis; Recurrence; Survival

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GERMANY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; RECURRENCE FREE SURVIVAL; ADVERSE EFFECTS; ALCOHOL ABSTINENCE; ALCOHOLIC BEVERAGE; BEER; COLORECTAL TUMOR; DRINKING BEHAVIOR; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY; WINE;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL ABSTINENCE; ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; BEER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE; WINE;

EID: 84973126955     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.127092     Document Type: Article

References (43)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer. Lyon (France): IARC; 2013.
2. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15:23-34.
3. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans: Volume 96. Alcoholic beverage consumption and ethyl carbamate (urethane). Lyon (France): IARC; 2010.
4. Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, Negri E, Straif K, Romieu I, La Vecchia C, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011; 22:1958-72.
5. Cai S, Li Y, Ding Y, Chen K, Jin M. Alcohol drinking and the risk of colorectal cancer death: a meta-analysis. Eur J Cancer Prev 2014; 23:532-9.
6. Eriksson CJ The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol Clin Exp Res 2001; 25(5 Suppl ISBRA):15S-32S.
7. Hamid A, Wani NA, Kaur J. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption: association with epigenome stability and cancer development. FEBS J 2009; 276:2175-91.
8. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol 2004; 39:155-65.
9. Pöschl G, Stickel F, Wang XD, Seitz HK. Alcohol and cancer: genetic and nutritional aspects. Proc Nutr Soc 2004; 63:65-71.
10. Zell JA, McEligot AJ, Ziogas A, Holcombe RF, Anton-Culver H. Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer 2007; 59:36-45.
11. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer 2011; 117:4948-57.
12. Pelser C, Arem H, Pfeiffer RM, Elena JW, Alfano CM, Hollenbeck AR, Park Y. Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH) - AARP Diet and Health Study. Cancer 2014; 120:1540-7.
13. Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006; 24:5017-24.
14. Fung TT, Kashambwa R, Sato K, Chiuve SE, Fuchs CS, Wu K, Giovannucci E, Ogino S, Hu FB, Meyerhardt JA. Post diagnosis diet quality and colorectal cancer survival in women. PLoS One 2014; 9: e115377.
15. Araújo RF Jr., Lira GA, Guedes HG, Cardoso MA, Cavalcante FJ, Araujo AL, Ramos CC, de Araujo AA. Lifestyle and family history influence cancer prognosis in Brazilian individuals. Pathol Res Pract 2013; 209:753-7.
16. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a populationbased, case-control study. Ann Intern Med 2011; 154:22-30.
17. Jansen L, Hoffmeister M, Arndt V, Chang-Claude J, Brenner H. Stagespecific associations between beta blocker use and prognosis after colorectal cancer. Cancer 2014; 120:1178-86.
18. Hoffmeister M, Jansen L, Rudolph A, Toth C, Kloor M, Roth W, Blaker H, Chang-Claude J, Brenner H. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. J Natl Cancer Inst 2015; 107:djv045.
19. Walter V, Jansen L, Hoffmeister M, Ulrich A, Chang-Claude J, Brenner H. Smoking and survival of colorectal cancer patients: populationbased study from Germany. Int J Cancer 2015; 137:1433-45.
20. Jansen L, Hoffmeister M, Chang-Claude J, Koch M, Brenner H, Arndt V. Age-specific administration of chemotherapy and long-term quality of life in stage II and III colorectal cancer patients: a population-based prospective cohort. Oncologist 2011; 16:1741-51.
21. Scherz H, Souci SW, editors. Food composition and nutrition tables. 5th ed. Stuttgart (Germany): Medpharm Scientific Publishers; 1994.
22. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010; 29:1037-57.
23. R: a language and environment for statistical computing. Version 3.1.0. Vienna (Austria): The R Foundation for Statistical Computing; 2014.
24. van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Soft 2011; 45:1-67.
25. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, Scotti L, Jenab M, Turati F, Pasquali E, et al. Alcohol consumption and sitespecific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 2015; 112:580-93.
26. Zhang C, Zhong M. Consumption of beer and colorectal cancer incidence: a meta-analysis of observational studies. Cancer Causes Control 2015; 26:549-60.
27. Ben Q, Wang L, Liu J, Qian A, Wang Q, Yuan Y. Alcohol drinking and the risk of colorectal adenoma: a dose-response meta-analysis. Eur J Cancer Prev 2015; 24:286-95.
28. Zhu JZ, Wang YM, Zhou QY, Zhu KF, Yu CH, Li YM. Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma. Aliment Pharmacol Ther 2014; 40:325-37.
29. Jin M, Cai S, Guo J, Zhu Y, Li M, Yu Y, Zhang S, Chen K. Alcohol drinking and all cancer mortality: a meta-analysis. Ann Oncol 2013; 24: 807-16.
30. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, Greenfield TK. Are lifetime abstainers the best control group in alcohol epidemiology?: on the stability and validity of reported lifetime abstention. Am J Epidemiol 2008; 168:866-71.
31. Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, Estruch R. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol 2013; 48:270-7.
32. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2009; 32:2123-32.
33. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005; 28:719-25.
34. Rajpathak SN, Freiberg MS, Wang C, Wylie-Rosett J, Wildman RP, Rohan TE, Robinson JG, Liu S, Wassertheil-Smoller S. Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: Women's Health Initiative Observational Study. Eur J Nutr 2010; 49:211-8.
35. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44(SUPPL. 2):S14-21.
36. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275:218-20.
37. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Bergmann C, Seiler N, Raul F. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 2000; 158:85-91.
38. Szende B, Tyihak E, Kiraly-Veghely Z. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp Mol Med 2000; 32:88-92.
39. Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates hostdefense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 2001; 39:102-7.
40. Kamei H, Hashimoto Y, Koide T, Kojima T, Hasegawa M. Anti-tumor effect of methanol extracts from red and white wines. Cancer Biother Radiopharm 1998; 13:447-52.
41. Yi W, Fischer J, Akoh CC. Study of anticancer activities of muscadine grape phenolics in vitro. J Agric Food Chem 2005; 53:8804-12.
42. Yi W, Fischer J, Krewer G, Akoh CC. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem 2005; 53:7320-9.
43. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 1988; 2:1267-73.